Goldman Capital Management’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.81M Buy
1,537,841
+128,540
+9% +$151K 1.76% 12
2017
Q3
$1.76M Buy
1,409,301
+239,691
+20% +$313K 1.67% 12
2017
Q2
$1.75M Buy
1,169,610
+203,800
+21% +$285K 1.86% 12
2017
Q1
$1.3M Buy
965,810
+93,408
+11% +$131K 1.25% 14
2016
Q4
$1.22M Buy
872,402
+299,202
+52% +$523K 1.06% 15
2016
Q3
$1.24M Buy
573,200
+190,200
+50% +$478K 1% 15
2016
Q2
$1.07M Buy
383,000
+126,234
+49% +$290K 0.92% 17
2016
Q1
$398K Buy
256,766
+33,969
+15% +$61.4K 0.3% 23
2015
Q4
$524K Buy
222,797
+2,797
+1% +$7.24K 0.41% 21
2015
Q3
$676K Buy
220,000
+10,000
+5% +$30.6K 0.48% 24
2015
Q2
$714K Buy
+210,000
New +$733K 0.45% 22

Other funds holding MLSS

Goldman Capital Management's MLSS Position: Q4 2017 in Review

Goldman Capital Management increased its Milestone Scientific (MLSS) stake by 9.1% in Q4 2017, buying an estimated $151K and bringing the position to 1,537,841 shares worth $1.81M. The position accounts for 1.76% of the portfolio, ranked #12.

Goldman Capital Management first reported a position in MLSS in Q2 2015 and has held it in 11 quarters since. 12 funds tracked by Wall St. Rank hold MLSS as of Q4 2017.

  • Goldman Capital Management held 1,537,841 shares of Milestone Scientific worth $1.81M as of Q4 2017.
  • Goldman Capital Management bought 128,540 Milestone Scientific shares in Q4 2017, an estimated $151K.
  • Milestone Scientific made up 1.76% of Goldman Capital Management's portfolio in Q4 2017, its #12 holding.
  • Goldman Capital Management first reported a position in Milestone Scientific in Q2 2015 and has held it in 11 quarters since.
  • 12 funds tracked by Wall St. Rank held Milestone Scientific as of Q4 2017.

Based on Goldman Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.